While lymphopenia may drive CD4+ TN cell loss, we may be able to intervene with dendritic cell (DC) vaccination, checkpoint blockade, or metabolic interventions during post-ASCT lymphopenia to better support the recovering T cell population. The gene discussed is CD4; the disease is lymphopenia.